 | | Molecular regulation of macrophages: implications for atherosclerosis |
|  | | Atherosclerosis is an inflammatory disease |
|
 | | Anti-inflammatory clinical trials |
|  | | Atherosclerosis is an inflammatory disease with a critical role for monocyte recruitment |
|
 | | Macrophages in human plaque development |
|  | | M1-M2 macrophage paradigm |
|
|  | | Macrophages in human plaque development |
|
 | | M1-M2 macrophage paradigm |
|  | | Type I interferons |
|
 | | Type I interferons: in vitro effects on macrophages |
|  | | Type I interferons: in vitro effects on macrophages |
|
 | | Type I interferons: in vitro effects on macrophages |
|  | | Static macrophage adhesion |
|
 | | In vivo leukocyte arrest |
|  | | IFNβ treatment of ldlr-/- mice |
|
 | | Human plaque transcriptome: comparing stable vs unstable lesions |
|
|
 | | What happens to the inflammatory phenotype when a macrophage becomes a foam cell? |
|  | | Foam cell formation by oxLDL switches macrophages to a pro-inflammatory state |
|
 | | M1-M2 macrophage paradigm |
|
Deel deze pagina met collega's en vrienden: